Navigation Links
New myeloma-obesity research shows drugs can team with body's defenses
Date:5/2/2014

Obesity increases the risk of myeloma, a cancer of plasma cells that accumulate inside the bones.

And with current obesity trends in the United States and especially in South Texas, that's ominous.

"I'm predicting an increase in multiple myeloma," said Edward Medina, M.D., Ph.D., "and with the obesity problems we see in the Hispanic population, there could be a serious health disparity on the horizon."

Dr. Medina, a hematopathologist and assistant professor in the Department of Pathology at The University of Texas Health Science Center at San Antonio, is looking at exactly how obesity causes an increased risk for myeloma.

What he and his colleagues have discovered is a potential way to not only boost the effectiveness of current chemotherapy treatments for myeloma, but at the same time a way to help the body help itself.

In a paper published this week in the journal Leukemia, Dr. Medina and his team look at an important little protein called adiponectin.

Myeloma is often called multiple myeloma because it occurs at many sites within the bone marrow. Healthy plasma cells produce antibodies that fight infection in the body, but myeloma cells produce high levels of abnormal antibodies that, when the cancer cells accumulate, they crowd out production of other important blood cells, both red and white.

"They basically overtake the bone marrow," Dr. Medina said.

The disease can lead to bone pain and fragility, confusion, excessive thirst and kidney failure. While survival rates for patients with myeloma have increased in recent years, many people do not live more than five years beyond diagnosis.

Adiponectin is a protective protein that plays several roles in keeping the body healthy, including killing cancer cells. While adiponectin is produced by fat cells, Medina said, obese people have less of it. The reason for this paradox is that in cases of obesity, fat cells function abnormally, including producing less adiponectin. What they produce more of, however, are fatty acids, and it is likely that myeloma cells can feed on these fatty acids.

"Synthesizing fatty acids is important for myeloma cells to build vital structures, including cell membranes, that enable them to keep on growing," Medina said.

Focusing on adiponectin led Dr. Medina's lab to protein kinase A or "PKA" a protein that, when activated by adiponectin, suppresses the fatty acids that myeloma cells need, leading to their demise.

The idea is to use the understanding of the pathways that adiponectin uses to kill myeloma cells to create a drug that would do the same thing.

"If we could pharmacologically suppress these fatty acid levels in obese myeloma patients, we could boost the effects of the chemotherapy that targets PKA or fatty acid synthesis, and potentially decrease the chemotherapeutic dose," Medina said. "Also, it would give your own body's protective measures more of a chance to work against the cancer."


'/>"/>

Contact: Elizabeth Allen
allenea@uthscsa.edu
210-450-2020
University of Texas Health Science Center at San Antonio
Source:Eurekalert

Related medicine news :

1. Researchers link age, general health and antidepressant use with eye disorders
2. St. Jude Childrens Research Hospital scientist elected to National Academy of Sciences
3. Researchers granted funding to explore novel lung cancer strategies
4. New UT Arlington research could improve pharmaceuticals testing
5. MS researchers find brain & cognitive reserve protect long-term against cognitive decline
6. UNC researchers discover master regulator role for little-known protein in cancer cells
7. The latest in scientific research in childrens health to be presented in Vancouver
8. CWRU researchers profile womens employment, caregiving workloads, effort and health
9. Stress research in therapy dogs reveals animals needs
10. Drug monitoring information improves regimen adherence, Carnegie Mellon researchers say
11. NIH center sets new goals for global health research and training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at www.diabetesscholars.org by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Surgical Procedure Volumes: Global Analysis (United States, ... Australia, Canada)" report to their offering. ... an essential tool for healthcare business planners, provides surgical ... looks at surgery trends with an in-depth analysis of ...
Breaking Medicine Technology: